A Peek Inside Turing Pharmaceuticals

A Peek Inside Turing Pharmaceuticals: 'Another $7.2 Million. Pow!'

Congressional investigators have pried loose emails showing how the company's executives anticipated huge profits from a 5000 percent drug ...

'Another $7.2 Million. Pow!' A Peek Inside Turing Pharmaceuticals ...

' A Peek Inside Turing Pharmaceuticals. Published February 2, 2016 at 12:25 ... Law enforcement at former President Donald Trump's Butler, Pennsylvania rally on ...

'Another $7.2 Million. Pow!' A Peek Inside Turing Pharmaceuticals

'Another $7.2 Million. Pow!' A Peek Inside Turing Pharmaceuticals. Published February 2, 2016 at 12:25 PM EST. Facebook · Twitter · LinkedIn · Email.

'Another $7.2 Million. Pow!' A Peek Inside Turing Pharmaceuticals

'Another $7.2 Million. Pow!' A Peek Inside Turing Pharmaceuticals. Published February 2, 2016 at 11:25 AM CST. Twitter · LinkedIn · Email.

"Another $7.2 Million. Pow!" A Peek Inside Turing Pharmaceuticals ...

"Another $7.2 Million. Pow!" A Peek Inside Turing Pharmaceuticals ... Subscribe to the Daily Digest, your five minute read to know what's happening in Iowa and ...

3. Turing Pharmaceuticals: a glimpse into controversial drug pricing.

Martin Shkreli, the CEO of Turing Pharmaceuticals at the time, was under the spotlight of global media after he greatly increased the price of an antiparasitic ...

'Another $7.2 Million. Pow!' A Peek Inside Turing Pharmaceuticals

Pow!' A Peek Inside Turing Pharmaceuticals. Published February 2, 2016 at 12:25 PM EST. Facebook · Twitter · LinkedIn · Email · Facebook · Twitter ...

Martin Shkreli Grins, Has No Comment At Hearing On Drug Prices

In Turing's defense, Retzlaff said that two-thirds of patients receive Daraprim at a steep discount through government programs, and that the ...

Newly Released Documents Show Profit-Seeking Behind Price ...

Newly Released Documents Show Profit-Seeking Behind Price Hikes at Turing, Valeant ... WASHINGTON/NEW YORK (Reuters)—A decision by Turing Pharmaceuticals to raise ...

Shkreli's Turing saw sales dive after price hike, lawmaker says

Sales of a drug manufactured by Turing Pharmaceuticals were said to have dropped precipitously after its CEO, Martin Shkreli, ...

Meet Health Care's Major Spoilers: Theranos, Valeant, and Turing ...

These pharmaceutical companies had agreed to pay $70 billion to support ACA in exchange for a legal restriction on the U.S. government in ...

After 5,000% Daraprim hike, pharma CEO 'would have raised prices ...

In August, Turing increased the price of Daraprim from $13.50 to $750 a capsule. Daraprim is a treatment for toxoplasmosis, a rare, parasitic ...

Martin Shkreli's drug company is losing money, documents show

The company gained notoriety in 2015 after Shkreli, then CEO, acquired Daraprim, which treats a rare infection called toxoplasmosis, and raised ...

Drug Goes From $13.50 a Tablet to $750, Overnight

The drug, called Daraprim, was acquired in August by Turing Pharmaceuticals, a start-up run by a former hedge fund manager. Turing immediately ...

Shkreli, Turing, and PhRMA | Science | AAAS

There have been a few developments in the Turing Pharmaceuticals affair. Martin Shkreli, after given several fantastically annoying ...

Martin Shkreli Is Replaced As Turing Pharmaceuticals CEO - WAMU

The executive, who has been in the news for his company's much-criticized price hike on a drug used by HIV patients — from around $13 to $750 — ...

Lawyer: Turing execs warned Shkreli against price hike

Turing's former general counsel told Senate lawmakers that the fiftyfold price increase on Daraprim, a drug used to treat a life-threatening ...

Turing Pharmaceuticals by browninga141 on emaze

Martin Shkreli, along with his company Turing Pharmaceuticals, made headlines when he acquired the rights to a popular drug Daraprim and drastically increased ...

Professionalism/Martin Shkreli, Turing Pharmaceuticals, and Daraprim

... a-peek-inside-turing-pharmaceuticals; ↑ Daraprim. (2016). Turing Pharmaceuticals. http://www.daraprimdirect.com/patients; ↑ Press Release ...

'Pharma bro' Martin Shkreli and the very American debate over ...

Prescription pricing is a strange thing to stir such rage, however. After all, Daraprim, the drug in question, is not widely used. It treats a ...